Graves’ disease is an autoimmune condition that can cause the thyroid to become overactive, affecting energy levels, heart rate, weight, and overall health. Tekton Research is enrolling participants in a clinical study evaluating an investigational medication for adults with Graves’ disease. Eligible participants may be reimbursed for study-related time and travel.
Eligible participants…
- Must be Ages 18 to 70
- Must have active hyperthyroidism due to Graves’ disease
- May receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Tekton enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.